Search research articles
Contact Us
Filters
Showing results (71-80 of 130) with videos related to
Page
of 13
Sort By:
International Journal of Antimicrobial Agents
|
May 2, 2006
Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003)
Jennifer M Streit, Ronald N Jones, Mark A Toleman, et al.
Antimicrobial Agents and Chemotherapy
|
February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018
Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
Computer Graphics Forum : Journal of the European Association for Computer Graphics
|
December 13, 2016
Pathfinder: Visual Analysis of Paths in Graphs
C Partl, S Gratzl, M Streit, et al.
Journal of Global Antimicrobial Resistance
|
November 21, 2018
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
The Journal of Antimicrobial Chemotherapy
|
January 29, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)
Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013
Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries
Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
February 8, 2018
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
Michael A Pfaller, Michael D Huband, Jennifer M Streit, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 130) with videos related to
Sort By:
Page
of 13
International Journal of Antimicrobial Agents
|
May 2, 2006
Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003)
Jennifer M Streit, Ronald N Jones, Mark A Toleman, et al.
Antimicrobial Agents and Chemotherapy
|
February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018
Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
Computer Graphics Forum : Journal of the European Association for Computer Graphics
|
December 13, 2016
Pathfinder: Visual Analysis of Paths in Graphs
C Partl, S Gratzl, M Streit, et al.
Journal of Global Antimicrobial Resistance
|
November 21, 2018
Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
The Journal of Antimicrobial Chemotherapy
|
January 29, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)
Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease
|
January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013
Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy
|
February 4, 2015
Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program
Helio S Sader, Robert K Flamm, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries
Michael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
International Journal of Antimicrobial Agents
|
February 8, 2018
Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)
Michael A Pfaller, Michael D Huband, Jennifer M Streit, et al.
Page
of 13